Showing results (41-50 of 300) with videos related to

Sort By:
Pageof 30
British Journal of Clinical Pharmacology|December 14, 1999
Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipientsH H Neumayer, K Paradis, A Korn, et al.
Cytokine|July 6, 2000
TNF-alpha and IL-1alpha induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengersT Böhler, J Waiser, H Hepburn, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Prognostic value of the Banff classificationJ Waiser, M Schreiber, K Budde, et al.
Kidney International|September 18, 1997
Glomerular epithelial cell products stimulate mesangial cell proliferation in cultureK Budde, H H Neumayer, D J Salant, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2007
Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patientsK Budde, S Bauer, P Hambach, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
FTY 720A mediates reduction of lymphocyte counts in human renal allograft recipients by an apoptosis-independent mechanismT Böhler, J Waiser, M Schütz, et al.
Transplantation Proceedings|September 19, 2006
Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantationN Kamar, P Glander, J Nolting, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
The quality of life in end stage renal disease careJ Waiser, K Budde, M Schreiber, et al.
Clinical Nephrology|August 31, 2006
Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic)K Budde, G Knoll, J Curtis, et al.
Clinical Nephrology|March 30, 2007
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximabK Budde, J L Bosmans, J Sennesael, et al.
Pageof 30